Literature DB >> 10551799

Constitutive and inducible in vivo protein-DNA interactions at the tumor necrosis factor-alpha promoter in primary human T lymphocytes.

C Becker1, K Barbulescu, S Wirtz, K H Meyer zum Büschenfelde, S Pettersson, M F Neurath.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a key cytokine of lymphocytes with major regulatory functions in immunomodulation, chronic inflammation, and septic shock. However, only limited information on TNF promoter regulation in vivo in primary lymphocytes is available. To determine and compare protein-DNA interactions at the native TNF locus in primary lymphocytes, we analyzed the human TNF-alpha promoter by ligation-mediated polymerase chain reaction (LM-PCR) techniques. Accordingly, primary CD4+ T lymphocytes from peripheral blood were cultured in the presence of various stimuli and analyzed by LM-PCR. Inducible in vivo protein-DNA interactions at the TNF promoter were detected between -120 and -70 bp of the human TNF promoter relative to the transcriptional start site. This area includes binding sites for transcription factors such as ETS-1, NFAT, ATF-2/c-jun, SP-1/Egr-1, and NF-kappaB. In contrast, no protein-DNA interactions were observed at various binding sites with reported regulatory function in tumor cell lines such as the k2 element, the NFAT site at -160, the AP1 site at -50, and the SP1 site at -65. Additional mutagenesis and transfection studies demonstrated that NF-kappaB and CREB/AP-1 are important regulators of inducible TNF promoter activity in primary human T lymphocytes. These results provide novel insights into the complex regulation of TNF gene transcription in primary T lymphocytes in vivo by constitutive and inducible protein-DNA interactions that appear to be at least partially different compared to previously characterized tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551799      PMCID: PMC6157389     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  41 in total

1.  Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide.

Authors:  A E Goldfeld; C Doyle; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Constitutive and inducible protein/DNA interactions of the interferon-gamma promoter in vivo in [corrected] CD45RA and CD45R0 T helper subsets.

Authors:  K Barbulescu; K H Meyer zum Büschenfelde; M F Neurath
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

3.  Luciferase reporter gene vectors for analysis of promoters and enhancers.

Authors:  S K Nordeen
Journal:  Biotechniques       Date:  1988-05       Impact factor: 1.993

4.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

6.  Interactive effects of the tumor necrosis factor promoter and 3'-untranslated regions.

Authors:  J Han; G Huez; B Beutler
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

7.  Regulation of the human TNF promoter by the transcription factor Ets.

Authors:  B Krämer; K Wiegmann; M Krönke
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

Review 8.  Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice.

Authors:  L Probert; K Akassoglou; L Alexopoulou; E Douni; S Haralambous; S Hill; G Kassiotis; D Kontoyiannis; M Pasparakis; D Plows; G Kollias
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 2.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

3.  Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli.

Authors:  O Sareila; R Korhonen; H Auvinen; M Hämäläinen; H Kankaanranta; E Nissinen; E Moilanen
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.